Key result
Subtherapeutic INR is not associated with increased 90-day thromboembolism in stable warfarin patients.
Why the study?
The absolute risk of thromboembolism associated with a significant subtherapeutic INR in patients with previously stable anticoagulation while receiving warfarin needed to be quantified.
Does a significant subtherapeutic INR increase the risk of anticoagulation-related thromboembolism in the ensuing 90 days compared to maintained therapeutic anticoagulation in adult patients previously stabilized on warfarin?
Cohort (n=2,597)
Does a significant subtherapeutic INR increase the risk of anticoagulation-related thromboembolism in the ensuing 90 days compared to maintained therapeutic anticoagulation in adult patients previously stabilized on warfarin?
Patients stabilized on warfarin who experience an isolated significant subtherapeutic INR have a low 90-day risk of thromboembolism similar to those maintaining therapeutic INRs, which does not support routine anticoagulant bridge therapy in this setting.
Answers are grounded in this paper and cite their sources.
Isolated subtherapeutic INR was associated with low thromboembolic risk; leaves open whether bridging is needed in stabilized warfarin patients.
Study Objective. To quantify the absolute risk of thromboembolism associated with a significant subtherapeutic international normalized ratio (INR) in patients with previously stable anticoagulation while receiving warfarin. Design. Retrospective, matched cohort analysis. Setting. Centralized anticoagulation service in an integrated health care delivery system. Patients. A total of 2597 adult patients receiving warfarin from January 1998‐December 2005; 1080 patients were in the low INR cohort and were matched to 1517 patients in the therapeutic INR cohort based on index INR date, indication for warfarin, and age. Measurements and Main Results. Stable, therapeutic anticoagulation was defined as two INR values, measured at least 2 weeks apart, within or above the therapeutic range. The low INR cohort included patients with a third INR value of 0.5 or more units below their therapeutic range. The therapeutic INR cohort included patients with a third therapeutic INR value and no INR value 0.2 or more units below their target INR range in the ensuing 90 days. The primary outcome was anticoagulation‐related thromboembolism during the 90 days after the index INR. Secondary outcomes were times to the first occurrence of anticoagulation‐related complications (bleeding, thromboembolism, or death) in the 90 days after the index INR. Four thromboembolic events (0.4%) occurred in the low INR cohort and one event (0.1%) in the therapeutic INR cohort (p=0.214). The differences in the proportions of thromboembolism, bleeding, or death were not significant between the cohorts (p>0.05). No significant differences were noted in the hazard of thromboembolism, bleeding, or death between the cohorts (p>0.05). Conclusion. Patients with stable INRs while receiving warfarin who experience a significant subtherapeutic INR value have a low risk of thromboembolism in the ensuing 90 days. The risk was similar to that observed in a matched control population in whom therapeutic anticoagulation was maintained. These findings do not support the practice of anticoagulant bridge therapy for patients stabilized on warfarin therapy to reduce their risk for thromboembolism during isolated periods of subtherapeutic anticoagulation.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2008) conducted a cohort in Patients receiving warfarin with previously stable anticoagulation (n=2,597). Significant subtherapeutic INR (third INR value >=0.5 units below therapeutic range) vs. Therapeutic INR (third therapeutic INR value and no INR value >=0.2 units below target range in ensuing 90 days) was evaluated on Anticoagulation-related thromboembolism during the 90 days after the index INR (p=0.214). A subtherapeutic INR in stable warfarin patients did not increase 90-day thromboembolism compared with maintaining a therapeutic INR.
Synapse has enriched 10 related papers. Consider them for comparative context: